Skip to content
Screener

NovoCure NVCR France — Net revenues

Other geography segments

United States
$102.96M
Germany
$23.34M
Japan
$11.78M
Greater China
$5.96M

Similar metrics at other companies

Albany International Inc. logo
AINFrance — Net revenues
$19.09M-5.9%
APi Group logo
APGFrance — Net revenues
$180M+11.8%
Albany International Inc. logo
AINBrazil — Net revenues
$17.16M+2.5%
Albany International Inc. logo
AINChina — Net revenues
$15.58M-8.0%
Albany International Inc. logo
AINMexico — Net revenues
$14.6M+0.8%
Albany International Inc. logo
AINSwitzerland — Net revenues
$27.69M+0.9%

Other financials

Income statement

See full
Revenue$183.6M+15.6%
Gross profit$142.5M+21.4%
Operating income-$10.6M+73.3%
Net income-$15.7M+61.0%
EPS (diluted)-$0.13+63.9%

Balance sheet

See full
Cash & equivalents$93.7M-37.4%
Total debt$37.5M-12.4%
Total equity$338.1M-3.2%
Total assets$795.2M-36.2%

Cash flow

See full
Operating cash flow$8.1M+151%
CapEx$6.9M+26.1%
Free cash flow$1.2M+106%

Valuation

See full
Market cap$1.91B+56.6%
Enterprise value$1.85B+66.6%
P/S2.7×+0.8×

Profitability

See full
Gross margin76.1%-0.3pp
Operating margin-22.1%-3.6pp
Net margin-21.2%-3.8pp
FCF margin-3.6%-1.5pp

Returns & leverage

See full
Return on equity-43.2%-4.0pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: NovoCure’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 6:59 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001645113-26-000062
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025Year ended Year ended December 31, 2025
United States$102,955$94,261$198,911$187,415$385,632
International markets:
Germany23,34119,07447,84537,79279,407
France21,34718,41644,22536,27576,189
Japan11,7809,48422,02318,19337,786
Other international markets18,20512,97933,88424,91656,898
International markets - Total74,67359,953147,977117,176250,280
Greater China (1)5,9564,59110,7519,20819,441

Item 1. Financial Statements

FAQ

What is NovoCure's france — net revenues?
NovoCure (NVCR) reported france — net revenues of $21.35M in Q2 2026.
How has NovoCure's france — net revenues changed year-over-year?
NovoCure's france — net revenues increased by 15.9% year-over-year, from $18.42M to $21.35M.
What does france — net revenues mean?
This metric represents the total gross sales generated from the commercialization of medical devices and therapeutic solutions within the French geographic market, net of any applicable returns, allowances, or discounts. It serves as a key indicator of the company's market penetration and adoption rates for its oncology treatment technologies in this specific region. Tracking this revenue stream allows investors to assess the growth trajectory and commercial success of the company's international expansion efforts.

Ask your AI about NovoCure's france — net revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude